| RNWFX | SSKEX | RNWFX / SSKEX | |
| Total Expense Ratio | 0.62 | 0.07 | 838% |
| Annual Report Gross Expense Ratio | 0.62 | 0.25 | 248% |
| Fund Existence | 24 years | 10 years | - |
| Gain YTD | 28.307 | 33.764 | 84% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 76.6B | 627M | 12,217% |
| Annual Yield % from dividends | 0.95 | 2.18 | 43% |
| Returns for 1 year | 21.74 | 30.58 | 71% |
| Returns for 3 years | 50.49 | 60.79 | 83% |
| Returns for 5 years | 26.64 | 31.99 | 83% |
| Returns for 10 years | 103.29 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IHE | 80.43 | 0.63 | +0.79% |
| iShares US Pharmaceuticals ETF | |||
| NOBL | 103.58 | 0.33 | +0.32% |
| ProShares S&P 500 Dividend Aristocrats | |||
| BFEB | 47.96 | 0.02 | +0.05% |
| Innovator U.S. Equity Buffer ETF™ - Feb | |||
| APXM | 30.81 | N/A | N/A |
| FT Vest U.S. Equity Max Buffr ETF - Apr | |||
| IWMW | 40.45 | -0.09 | -0.22% |
| iShares Russell 2000 BuyWrite ETF | |||